KALV KalVista Pharmaceuticals Inc Year-over-year net earnings per share growth for the last 12 months

KalVista Pharmaceuticals Inc - graphic logo of issuer KALV

The quarterly EPS growth marker demonstrates the profit dynamics of KalVista Pharmaceuticals (KALV), generated through partnerships with medical centers to develop angioedema drugs. The 59.60 mark reflects fresh data while the company incurs significant R&D costs prior to reaching the sales stage. However, intense pressure from pharma behemoths makes the success of future clinical trials a critical condition for the business's survival.

kalvista.com (KALV) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 06/21/2026

KALV (KalVista Pharmaceuticals): analytical breakdowns and indicator data

- market value and analyst target forecast:
Initial company analysis:KalVista Pharmaceuticals
Manufactured product of KalVista Corp

Quarterly EPS growth determines the dynamics of net profit per share, reflecting the efficiency of capital generation. This metric measures the percentage change in earnings between reporting periods, revealing the pace of business scaling. By analyzing the amplitude of quarterly EPS fluctuations, an investor captures the asset's reaction to macroeconomic shocks. For KalVista Pharmaceuticals (KALV), this indicator will become key during the transition to drug commercialization. The product launch will create an autonomous profit vector, minimizing dependence on market conditions.

Direct competitors

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth SVRA (savarapharma.com)|Year-over-year earnings per one share growth for the last 12 months RIGL|ANAB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ATXS (Astria Therapeutics, Inc.)|ENGN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Year-over-year earnings per share growth for the last twelve months aerovatetx.com|Quarterly EPS earnings growth aclaristx.com|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months Tiziana Life Sciences Ltd|Quarterly EPS earnings growth CABA (Cabaletta Bio Inc)|VTYX: Year-over-year earnings per share growth for the last 12 months|Theratechnologies, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Agenus Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Climb Bio|Quarterly EPS earnings growth Zura Bio Ltd|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr Pharma Inc)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months